These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 37854093)
1. Live-Attenuated VEEV Vaccine Delivered by iDNA Using Microneedles Is Immunogenic in Rabbits. Tretyakova I; Tomai M; Vasilakos J; Pushko P Front Trop Dis; 2022 Mar; 3():. PubMed ID: 37854093 [TBL] [Abstract][Full Text] [Related]
3. Venezuelan equine encephalitis vaccine with rearranged genome resists reversion and protects non-human primates from viremia after aerosol challenge. Tretyakova I; Plante KS; Rossi SL; Lawrence WS; Peel JE; Gudjohnsen S; Wang E; Mirchandani D; Tibbens A; Lamichhane TN; Lukashevich IS; Comer JE; Weaver SC; Pushko P Vaccine; 2020 Apr; 38(17):3378-3386. PubMed ID: 32085953 [TBL] [Abstract][Full Text] [Related]
4. Novel vaccine against Venezuelan equine encephalitis combines advantages of DNA immunization and a live attenuated vaccine. Tretyakova I; Lukashevich IS; Glass P; Wang E; Weaver S; Pushko P Vaccine; 2013 Feb; 31(7):1019-25. PubMed ID: 23287629 [TBL] [Abstract][Full Text] [Related]
5. Single-Dose Immunogenic DNA Vaccines Coding for Live-Attenuated Alpha- and Flaviviruses. Pushko P; Lukashevich IS; Johnson DM; Tretyakova I Viruses; 2024 Mar; 16(3):. PubMed ID: 38543793 [TBL] [Abstract][Full Text] [Related]
6. Advanced Safety and Genetic Stability in Mice of a Novel DNA-Launched Venezuelan Equine Encephalitis Virus Vaccine with Rearranged Structural Genes. Johnson DM; Sokoloski KJ; Jokinen JD; Pfeffer TL; Chu YK; Adcock RS; Chung D; Tretyakova I; Pushko P; Lukashevich IS Vaccines (Basel); 2020 Mar; 8(1):. PubMed ID: 32121666 [TBL] [Abstract][Full Text] [Related]
7. DNA vaccine initiates replication of live attenuated chikungunya virus in vitro and elicits protective immune response in mice. Tretyakova I; Hearn J; Wang E; Weaver S; Pushko P J Infect Dis; 2014 Jun; 209(12):1882-90. PubMed ID: 24585894 [TBL] [Abstract][Full Text] [Related]
8. Replication and clearance of Venezuelan equine encephalitis virus from the brains of animals vaccinated with chimeric SIN/VEE viruses. Paessler S; Ni H; Petrakova O; Fayzulin RZ; Yun N; Anishchenko M; Weaver SC; Frolov I J Virol; 2006 Mar; 80(6):2784-96. PubMed ID: 16501087 [TBL] [Abstract][Full Text] [Related]
9. A Phase 1 clinical trial of a DNA vaccine for Venezuelan equine encephalitis delivered by intramuscular or intradermal electroporation. Hannaman D; Dupuy LC; Ellefsen B; Schmaljohn CS Vaccine; 2016 Jun; 34(31):3607-12. PubMed ID: 27206386 [TBL] [Abstract][Full Text] [Related]
11. Plasmid DNA initiates replication of yellow fever vaccine in vitro and elicits virus-specific immune response in mice. Tretyakova I; Nickols B; Hidajat R; Jokinen J; Lukashevich IS; Pushko P Virology; 2014 Nov; 468-470():28-35. PubMed ID: 25129436 [TBL] [Abstract][Full Text] [Related]
12. A roadmap for developing Venezuelan equine encephalitis virus (VEEV) vaccines: Lessons from the past, strategies for the future. Han L; Song S; Feng H; Ma J; Wei W; Si F Int J Biol Macromol; 2023 Aug; 245():125514. PubMed ID: 37353130 [TBL] [Abstract][Full Text] [Related]